The prognostic significance of tumor-associated neutrophils and circulating neutrophils in glioblastoma (WHO CNS5 classification)

[1] Louis DN(2021)The 2021 WHO classification of tumors of the central nervous system: a summary Neuro-Oncology 23 1231-1251

[2] Perry A(2021)Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China Future Oncol 17 4571-4582

[3] Wesseling P(2020)Management of glioblastoma: state of the art and future directions CA Cancer J Clin 70 299-312

[4] Brat DJ(2018)Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014 JAMA Oncol 4 1254-1262

[5] Cree IA(2022)Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system Cancer 128 47-58

[6] Figarella-Branger D(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[7] Hawkins C(2009)Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study Neuroepidemiology 32 21-29

[8] Ng HK(2017)Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy Neuro-Oncology 19 394-404

[9] Pfister SM(2020)Molecular correlates of long survival in IDH-wildtype glioblastoma cohorts J Neuropathol Exp Neurol 79 843-854

[10] Reifenberger G(2017)Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment Cancer Cell 32 42-56.e46

[1] Louis DN(2021)The 2021 WHO classification of tumors of the central nervous system: a summary Neuro-Oncology 23 1231-1251

[2] Perry A(2021)Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China Future Oncol 17 4571-4582

[3] Wesseling P(2020)Management of glioblastoma: state of the art and future directions CA Cancer J Clin 70 299-312

[4] Brat DJ(2018)Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014 JAMA Oncol 4 1254-1262

[5] Cree IA(2022)Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system Cancer 128 47-58

[6] Figarella-Branger D(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[7] Hawkins C(2009)Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study Neuroepidemiology 32 21-29

[8] Ng HK(2017)Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy Neuro-Oncology 19 394-404

[9] Pfister SM(2020)Molecular correlates of long survival in IDH-wildtype glioblastoma cohorts J Neuropathol Exp Neurol 79 843-854

[10] Reifenberger G(2017)Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment Cancer Cell 32 42-56.e46